Research institution
Virginia Commonwealth University Clinical Trials
Studies where Virginia Commonwealth University is the lead sponsor: what is enrolling now, by phase, condition and country.
In numbers
Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.
Open to volunteers
All 80Tetraplegia/Tetraparesis
Transspinal Stimulation With and Without Blood Flow Restricted Exercise Via Telehealth in Persons With Tetraplegia
The purpose of the current study is to evaluate whether a home-based, telehealth-supported intervention combining Blood Flow Restricted Exercise (BES) and Transspinal Stimulation (TS) will improve motor and functional abilities…
- Trial name
- SCIMS Main (NCT05423600)
- Testing
- BES + TS
- Where
- 3 sites in United States
- Volunteers
- 44 people
- Sponsor
- Virginia Commonwealth University
Symptoms and Signs, Cancer
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors
- Conditions
- Symptoms and Signs, Cancer, Childhood Cancer
- Trial name
- NCT05958316
- Testing
- Computerized Symptom Capture Tool (C-SCAT) Intervention, Usual Care Control
- Where
- 5 sites in United States
- Volunteers
- 126 people
- Sponsor
- Virginia Commonwealth University
Breast Cancer
Single FrAction Interstitial BreaSt BracHytherApy
This phase 2, single arm prospective study has been designed to determine the safety of delivering accelerated partial breast irradiation (APBI) with a multicatheter interstitial implant in a single fraction over 1 day.
- Trial name
- SASHA (NCT07654257)
- Testing
- Partial Breast Irradiation
- Where
- United States
- Volunteers
- 134 people
- Sponsor
- Virginia Commonwealth University
Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
This study will garner preliminary data to develop a young adult-mediated intervention whereby a younger family member encourages their older family member to get colorectal cancer (CRC) screening.
- Trial name
- NCT05936931
- Testing
- Changes in CRC screening awareness and intentions
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Virginia Commonwealth University
Breast Cancer, Supportive Care in Cancer
EMBRACE (EMPA in BReast Cancer for Activity and Cardiac ProtEction)
The primary objective of this pilot study is to evaluate the feasibility and acceptability of a clinical trial protocol investigating 10 mg/day empagliflozin in breast cancer patients receiving anthracycline-based chemotherapy.
- Trial name
- EMBRACE (NCT07883512)
- Testing
- Empagliflozin
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Virginia Commonwealth University
DM1, Myotonic Dystrophy
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
Myotonic Dystrophy type 1 (DM1) is an autosomal dominant multisystemic disorder that causes progressive disability and shortened life expectancy.
- Conditions
- DM1, Myotonic Dystrophy, Myotonic Dystrophy 1, Myotonic Dystrophy Type 1
- Trial name
- END-EXT (NCT07700225)
- Where
- United States
- Volunteers
- 1,000 people
- Sponsor
- Virginia Commonwealth University
Dementia
Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic
Since the "National Partnership to Improve Dementia Care" debuted in 2012, almost all long-stay psychoactive prescribing has been graded by CMS, which has correlated to decreased use.
- Trial name
- NCT06095284
- Testing
- Pre-Extraction Phase, Extraction Phase, Post-Extraction Phase
- Where
- United States
- Volunteers
- 22,500,000 people
- Sponsor
- Virginia Commonwealth University
Violence
A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults
The overall aim of the proposed project is to develop and evaluate the effectiveness of Brief Violence Intervention-Virtual Reality (BVI-VR) for reducing firearm-related violence, re-injury, and mortality among victims of…
- Trial name
- NCT06239285
- Testing
- Brief Violence Intervention VR (BVI-VR), Treatment as Usual (TAU)
- Where
- United States
- Volunteers
- 220 people
- Sponsor
- Virginia Commonwealth University
Violence, Exposure to Violent Event
Evaluation of Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Violence
The goal of this research study is to implement and evaluate a comprehensive community-level approach, Healthy Communities for Youth, that includes both a selective hospital-based prevention strategy, Emerging Leaders, and…
- Conditions
- Violence, Exposure to Violent Event, Adolescent Behavior
- Trial name
- NCT06176300
- Testing
- PAR - the SEED Method, PAR-Youth Voices, Emerging Leaders hospital-based intervention
- Where
- United States
- Volunteers
- 3,390 people
- Sponsor
- Virginia Commonwealth University
Androgen Deprivation Therapy, Prostate Cancer
Autonomic and Renal Contributions to Hypertension With ADT
This study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer.
- Conditions
- Androgen Deprivation Therapy, Prostate Cancer, Hypertension, Autonomic Dysfunction
- Trial name
- ARCH (NCT07848828)
- Testing
- Gonadotropin Releasing Hormone Agonists (GNRH), Androgen receptor (AR) inhibitor
- Where
- United States
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Virginia Commonwealth University
Completed, with results posted
All 130Parkinson Disease, Cognitive Impairment
Istradefylline for Parkinson Disease With Cognitive Impairment
The purpose of this research study is to determine whether istradefylline improves cognition in individuals with Parkinson disease with cognitive impairment.
- Trial name
- NCT05333549
- Testing
- Istradefylline medication
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Virginia Commonwealth University
Obesity
Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management
African American adults that live in economically disadvantaged areas are at an increased risk for obesity and cardiometabolic disease.
- Trial name
- NCT05544708
- Testing
- Wellness Engagement Intervention
- Where
- United States
- Volunteers
- 43 people, healthy volunteers welcome
- Sponsor
- Virginia Commonwealth University
Addiction, Opioid Use
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
The overall goal of this project is to collect initial human data on the effects of novel compounds on safety (interactions with an opioid drug, e.g., buprenorphine) and early efficacy signals (subjective effects on negative…
- Conditions
- Addiction, Opioid Use, Substance Use Disorders, Opioid Use Disorder
- Trial name
- NCT05976646
- Testing
- Auvelity
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Virginia Commonwealth University
Perinatal Depression
"Mamma Mia" for Perinatal Health and Wellness
The purpose of this research study is to find out about ways to enhance well-being during pregnancy and the postpartum period (after the baby is born).
- Trial name
- NCT04300894
- Testing
- Mamma Mia, Mamma Mia Plus
- Where
- United States
- Volunteers
- 1,757 people
- Sponsor
- Virginia Commonwealth University
Conduct Disorder, Conduct Disorders in Children
Impact VR: An Emotion Recognition and Regulation Training Program for Youth With CD
Conduct disorder (CD) is one of the most prevalent childhood psychiatric disorders. Unfortunately, there are limited treatments available for CD.
- Conditions
- Conduct Disorder, Conduct Disorders in Children, Conduct Disorders in Adolescence, Callous-Unemotional Traits
- Trial name
- NCT06301516
- Testing
- Virtual Reality, Comparative Control
- Where
- United States
- Volunteers
- 220 people
- Sponsor
- Virginia Commonwealth University